Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-26 09:16 am Purchase |
2025-02-17 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management, LLC | 2,527,084 9.990% |
2,527,084 (New Position) |
Filing History |
| 2025-02-13 1:44 pm Sale |
2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 657,614 6.200% |
-15,296 (-2.27%) |
Filing History |
| 2024-11-14 5:17 pm Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 672,910 6.500% |
428,619 (+175.45%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 504,550 4.990% |
349,782 (+226.00%) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 244,291 9.900% |
244,291 (New Position) |
Filing History |
| 2024-02-06 10:23 am Sale |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 154,768 6.600% |
-12,371 (-7.40%) |
Filing History |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 167,139 7.600% |
167,139 (New Position) |
Filing History |
| 2022-02-28 4:30 pm Purchase |
2021-12-02 | 13D | Petros Pharmaceuticals, Inc. PTPI |
SHULMAN JOHN D | 788,093 34.470% |
113,635 (+16.85%) |
Filing History |
| 2022-02-23 4:25 pm Purchase |
2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management, LLC | 119,420 4.990% |
46,992 (+64.88%) |
Filing History |
| 2022-02-11 07:54 am Purchase |
2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 160,167 7.200% |
102,266 (+176.62%) |
Filing History |
| 2022-02-10 2:46 pm Sale |
2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
HAYWOOD GEORGE WEAVER | 4,500 0.200% |
-97,123 (-95.57%) |
Filing History |
| 2021-10-27 09:47 am Purchase |
2021-10-19 | 13G | Petros Pharmaceuticals, Inc. PTPI |
HAYWOOD GEORGE WEAVER | 101,623 7.600% |
101,623 (New Position) |
Filing History |
| 2021-10-22 06:51 am Purchase |
2021-10-18 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management, LLC | 72,428 9.990% |
72,428 (New Position) |
Filing History |
| 2021-10-20 5:25 pm Purchase |
2021-10-18 | 13D | Petros Pharmaceuticals, Inc. PTPI |
SHULMAN JOHN D | 674,458 51.190% |
334,861 (+98.61%) |
Filing History |
| 2021-01-29 06:14 am Unchanged |
2020-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 57,900 5.700% |
0 (Unchanged) |
Filing History |
| 2021-01-20 4:26 pm Purchase |
2020-12-01 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 57,900 5.700% |
57,900 (New Position) |
Filing History |
| 2020-12-11 5:26 pm Purchase |
2020-12-01 | 13D | Petros Pharmaceuticals, Inc. PTPI |
SHULMAN JOHN D | 339,596 34.900% |
339,596 (New Position) |
Filing History |